Biofidelity Funding: $60M Raised, Series A+ (2024)

Biofidelity is based in Cambridge, UK. It has raised $60M in total funding. Latest round: Series A+.

Biofidelity funding overview

Biofidelity is based in Cambridge, UK. Biofidelity has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A+ announced in July 2024. The round record for Biofidelity runs through 2024; nothing later has been disclosed. Investors on record include Agilent Technologies, Octopus Ventures, BlueYard Capital, Longwall Ventures. 4 distinct backers are named across the disclosed rounds.

Biofidelity at a glance

Total raised
$60M
Latest round
Series A+
Latest round date
July 2024
Headquarters
Cambridge, UK
Notable investors
Agilent Technologies, Octopus Ventures, BlueYard Capital, Longwall Ventures

Frequently asked about Biofidelity funding

How much has Biofidelity raised?
Biofidelity has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Biofidelity?
Agilent Technologies, Octopus Ventures, BlueYard Capital, Longwall Ventures are named among the investors backing Biofidelity.
What was the latest Biofidelity funding round?
The most recent disclosed round is a Series A+, announced in July 2024.
Where is Biofidelity based?
Biofidelity is based in Cambridge, UK.
When did Biofidelity last raise?
The last disclosed Biofidelity round closed in July 2024 at Series A+.

Round data for Biofidelity is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Cambridge and backer lists below.

Companies related to Biofidelity (23)

Browse related funding lists (6)

Company funding database · Investor directory · Founder database · Mega-rounds 2026